Balentine LLC Regeneron Pharmaceuticals, Inc. Transaction History

Balentine LLC

$3.35 Billion
Q1 2024

A detailed history of Balentine LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Balentine LLC holds 3,278 shares of REGN stock, worth $3.42 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,278

Previous 3,399 3.56%

Holding current value

$3.42 Million

Previous $2.99 Million 5.7%

% of portfolio

0.09%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $109,225 - $120,195	-121 Reduced 3.56%	3,278 $3.16 Million
Q4 2023 Feb 09, 2024	BUY	$775.18 - $881.7 $75,192 - $85,524	97 Added 2.94%	3,399 $2.99 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $31,160 - $37,996	45 Added 1.38%	3,302 $2.72 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $22,400 - $26,571	32 Added 0.99%	3,257 $2.34 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $266,071 - $323,345	-391 Reduced 10.81%	3,225 $2.65 Million

Q4 2022 Jan 31, 2023	BUY	$705.89 - $766.39 $285,885 - $310,387	405 Added 12.61%	3,616 $2.61 Million
Q3 2022 Oct 26, 2022	SELL	$573.97 - $724.32 $375,950 - $474,429	-655 Reduced 16.94%	3,211 $2.21 Million
Q2 2022 Oct 26, 2022	BUY	$548.35 - $738.84 $870,231 - $1.17 Million	1,587 Added 69.64%	3,866 $2.29 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $870,231 - $1.17 Million	1,587 Added 69.64%	3,866 $2.29 Million
Q1 2022 Oct 26, 2022	SELL	$595.12 - $698.43 $944,455 - $1.11 Million	-1,587 Reduced 41.05%	2,279 $1.59 Million
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $983,138 - $1.15 Million	1,652 Added 263.48%	2,279 $1.59 Million
Q4 2021 Oct 26, 2022	SELL	$543.48 - $670.97 $1.76 Million - $2.17 Million	-3,239 Reduced 83.78%	627 $396,000
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $23,913 - $29,522	44 Added 7.55%	627 $396,000
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $334,659 - $396,999	583 New	583 $353,000
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $53,930 - $65,162	-99 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $4,439 - $5,795	9 Added 10.0%	99 $62,000
Q1 2020 May 18, 2020	BUY	$336.18 - $494.43 $28,911 - $42,520	86 Added 2150.0%	90 $44,000
Q3 2019 Nov 15, 2019	SELL	$273.46 - $318.39 $820 - $955	-3 Reduced 42.86%	4 $1,000
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $2,097 - $2,903	7 New	7 $2,000
Q1 2018 May 16, 2018	SELL	$315.82 - $393.78 $9,790 - $12,207	-31 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $9,683 - $12,688	-27 Reduced 46.55%	31 $12,000
Q3 2017 Nov 15, 2017	BUY	$431.38 - $504.0 $25,020 - $29,232	58	58 $26,000

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balentine LLC with notifications on news.

Account